Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
2(10%)
Results Posted
33%(3 trials)
Terminated
2(10%)

Phase Distribution

Ph not_applicable
1
5%
Ph phase_3
5
25%
Ph phase_2
7
35%
Ph phase_4
3
15%
Ph phase_1
4
20%

Phase Distribution

4

Early Stage

7

Mid Stage

8

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
4(20.0%)
Phase 2Efficacy & side effects
7(35.0%)
Phase 3Large-scale testing
5(25.0%)
Phase 4Post-market surveillance
3(15.0%)
N/ANon-phased studies
1(5.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

9 of 12 finished

Non-Completion Rate

25.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

20

all time

Status Distribution
Active(5)
Completed(9)
Terminated(3)
Other(3)

Detailed Status

Completed9
unknown3
Not yet recruiting3
Terminated2
Recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
2
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (20.0%)
Phase 27 (35.0%)
Phase 35 (25.0%)
Phase 43 (15.0%)
N/A1 (5.0%)

Trials by Status

unknown315%
completed945%
not_yet_recruiting315%
recruiting15%
active_not_recruiting15%
terminated210%
withdrawn15%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07054801Phase 2

IA Lidocaine and Methylprednisolone for Headache Associated With Subarachnoid Hemorrhage

Not Yet Recruiting
NCT06360458Phase 3

Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke

Active Not Recruiting
NCT06462781Phase 1

Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1

Completed
NCT07202143Phase 3

Methylprednisolone for Stroke With Large Infarct Core and Post-stroke Lymphocytopenia

Recruiting
NCT07185633Phase 2

Study of Gecacitinib-corticosteroid as First-line Therapy for Grade II-IV Acute Graft Versus Host Disease

Not Yet Recruiting
NCT07175649Not Applicable

Methylprednisolone Sodium Succinate With Endovascular ThRombectomy for Large Ischemic STroke

Not Yet Recruiting
NCT04377503Phase 2

Tocilizumab Versus Methylprednisolone in the Cytokine Release Syndrome of Patients With COVID-19

Terminated
NCT03745664Phase 3

Corticosteroids and Myocardial Injury in CAP (COLOSSEUM TRIAL)

Unknown
NCT04343729Phase 2

Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19

Completed
NCT02779283Phase 1

Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Completed
NCT04219995Phase 1

Pilot Trial to Evaluate The Effect of Oral Methylprednisolone on Seizure Frequency in Children With Epilepsy

Unknown
NCT00568633Phase 3

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Terminated
NCT03082092Phase 4

Pre-operative Intravenous Steroid in Total Knee Replacement for Pain Relief and Recovery

Completed
NCT04007328Phase 2

Sphingosine-1-phosphate and Pneumonia

Unknown
NCT02425813Phase 2

Methylprednisolone Sodium Succinate in Treating Patients With Acute Graft-versus-Host Disease of the Gastrointestinal Tract

Withdrawn
NCT01977781Phase 1

Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease

Completed
NCT00097448Phase 3

Sudden Deafness Treatment Trial

Completed
NCT02317601Phase 4

Preoperative Single Glucocorticoid Hip Fracture Hip Fracture Surgery

Completed
NCT01167946Phase 4

Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata

Completed
NCT00290602Phase 2

Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20